Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Bristol-Myers Squibb Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term debt obligations 3,554 2,046 1,078 3,531 6,190 3,119 5,467 3,020 2,752 4,264 2,132 4,953 7,522 4,948 5,065 2,655 1,777 2,340 3,585 4,819 3,862
Accounts payable 4,002 3,602 3,469 3,751 3,539 3,259 2,813 3,069 3,194 3,040 2,595 2,882 2,944 2,949 2,695 3,609 2,972 2,713 2,441 2,852 3,069
Other current liabilities 16,514 18,126 18,091 15,983 16,093 15,884 15,182 14,061 13,139 14,586 14,203 13,080 12,355 13,971 13,700 12,727 12,581 14,027 14,438 15,750 12,301
Current liabilities 24,070 23,774 22,638 23,265 25,822 22,262 23,462 20,150 19,085 21,890 18,930 20,915 22,821 21,868 21,460 18,991 17,330 19,080 20,464 23,421 19,232
Deferred income taxes 276 369 430 461 442 338 399 751 1,568 2,166 2,881 3,034 3,809 4,501 4,956 4,931 5,235 5,407 5,913 6,157 6,531
Long-term debt, excluding current portion 46,157 47,603 48,674 48,858 49,487 36,653 32,137 34,656 35,078 35,056 36,966 37,107 37,450 39,605 39,677 42,503 44,505 48,336 41,364 41,853 42,844
Other non-current liabilities 4,476 4,469 4,728 4,993 6,732 6,421 6,203 5,902 6,664 6,590 6,685 6,640 7,309 7,334 7,516 7,498 7,692 7,776 7,565 7,485 10,701
Non-current liabilities 50,909 52,441 53,832 54,312 56,661 43,412 38,739 41,309 43,310 43,812 46,532 46,781 48,568 51,440 52,149 54,932 57,432 61,519 54,842 55,495 60,076
Total liabilities 74,979 76,215 76,470 77,577 82,483 65,674 62,201 61,459 62,395 65,702 65,462 67,696 71,389 73,308 73,609 73,923 74,762 80,599 75,306 78,916 79,308
Preferred stock
Common stock 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292 292
Capital in excess of par value of stock 46,012 46,024 45,896 45,766 45,655 45,684 44,849 45,299 45,140 45,165 44,956 44,375 43,756 44,361 44,292 44,064 43,852 44,325 44,435 44,444 43,254
Accumulated other comprehensive loss (1,424) (1,238) (1,468) (1,456) (1,400) (1,546) (1,286) (1,387) (1,368) (1,281) (841) (992) (1,229) (1,268) (1,424) (1,518) (1,544) (1,839) (1,699) (1,556) (1,549)
Retained earnings 16,106 14,912 16,097 16,103 15,640 28,766 28,218 27,449 26,568 25,503 24,675 24,217 23,948 23,820 22,625 22,168 22,204 21,281 32,414 31,565 32,671
Cost of treasury stock (43,597) (43,655) (43,675) (43,690) (43,697) (43,766) (43,075) (39,680) (38,808) (38,618) (36,411) (35,292) (35,187) (31,259) (28,572) (28,198) (27,199) (26,237) (25,284) (25,651) (24,757)
Total BMS shareholders’ equity 17,389 16,335 17,142 17,015 16,490 29,430 28,998 31,973 31,824 31,061 32,671 32,600 31,580 35,946 37,213 36,808 37,605 37,822 50,158 49,094 49,911
Noncontrolling interest 59 53 58 54 58 55 64 57 62 57 63 61 65 60 71 66 68 60 72 66 66
Total equity 17,448 16,388 17,200 17,069 16,548 29,485 29,062 32,030 31,886 31,118 32,734 32,661 31,645 36,006 37,284 36,874 37,673 37,882 50,230 49,160 49,977
Total liabilities and equity 92,427 92,603 93,670 94,646 99,031 95,159 91,263 93,489 94,281 96,820 98,196 100,357 103,034 109,314 110,893 110,797 112,435 118,481 125,536 128,076 129,285

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Short-term debt obligations
Short-term debt displayed considerable fluctuations throughout the observed period. Starting at $3,862 million in Q1 2020, it surged to a peak of $7,522 million in Q1 2022 before declining significantly to $1,078 million in Q3 2024. This volatility suggests active management of short-term financing needs.
Accounts payable
Accounts payable remained relatively stable with mild fluctuations around the $3,000 million mark. A slight increasing trend is observed towards the end of the series, reaching approximately $4,002 million by Q1 2025, indicating a gradual rise in company payables.
Other current liabilities
Other current liabilities showed variability, peaking near $18,126 million in Q4 2024 after an overall upward trajectory from $12,301 million in Q1 2020. This reflects a growing portion of current obligations outside of payables and short-term debt.
Current liabilities
Current liabilities in total demonstrated volatility but with a moderate upward movement, ranging from $19,232 million in Q1 2020 to $24,070 million in Q1 2025, suggesting an increase in liabilities due within a year, driven largely by other current liabilities and short-term debt changes.
Deferred income taxes
Deferred income taxes consistently declined over the period, dropping from $6,531 million in Q1 2020 to $276 million by Q1 2025. This steady decrease signals a reduction in deferred tax liabilities or changes in tax strategy or asset valuations affecting deferred taxes.
Long-term debt, excluding current portion
Long-term debt decreased from $42,844 million in Q1 2020 to $32,137 million by Q4 2021 but showed a rebound thereafter, reaching $49,487 million in Q2 2024 before a slight decrease to $46,157 million in Q1 2025. This pattern indicates episodic borrowings or refinancings over the period.
Other non-current liabilities
Other non-current liabilities decreased overall from $10,701 million in Q1 2020 to around $4,476 million in Q1 2025, suggesting repayments or reductions in long-term non-debt obligations.
Non-current liabilities
Non-current liabilities diminished from $60,076 million in Q1 2020 to $38,739 million by Q4 2021, followed by an increase peaking at $56,661 million in Q2 2024 before stabilizing around $50,909 million in Q1 2025. This reflects underlying changes in long-term financing and obligations.
Total liabilities
Total liabilities followed a somewhat downward trend from $79,308 million in Q1 2020 to approximately $62,395 million in Q1 2023, but rose again to $82,483 million by Q2 2024 before easing to $74,979 million in Q1 2025. This suggests changing leverage and liability management.
Equity components
Common stock remained constant at $292 million throughout. Capital in excess of par value showed a gradual increase from $43,254 million to around $46,012 million, indicating additional paid-in capital growth. Accumulated other comprehensive loss fluctuated but stayed negative, generally near -$1,400 million, exposing some losses from comprehensive income items.
Retained earnings
Retained earnings initially rose from $32,671 million in Q1 2020 to a peak near $28,766 million in Q4 2022 but then dramatically declined to approximately $14,912 million in Q1 2025, indicating either significant losses or distributions offsetting accumulated earnings.
Cost of treasury stock
The cost of treasury stock steadily increased in absolute value (more negative), starting at -$24,757 million and reaching a level near -$43,597 million by Q1 2025, which signals ongoing stock repurchases or treasury shares accumulation.
Total shareholders’ equity and total equity
Total shareholders’ equity dropped from $49,911 million in Q1 2020 to a low of about $16,490 million in Q1 2024 before a slight recovery, ending near $17,389 million in Q1 2025. Total equity mirrored this pattern, declining sharply and modestly recovering. This decline contrasts with stable or growing liabilities, suggesting challenges in equity value maintenance.
Total liabilities and equity
The sum of liabilities and equity decreased steadily from $129,285 million in Q1 2020 to approximately $92,427 million in Q1 2025, indicating a reduction in overall company capitalization and liabilities, possibly due to asset sales, restructuring, or other strategic financial decisions.